NCT04362254View on ClinicalTrials.gov

A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials

PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

May 14, 2022

Study Completion Date

September 23, 2022

Conditions
Crohn Disease
Interventions
DRUG

Spesolimab

Spesolimab

Trial Locations (7)

1090

AKH - Medical University of Vienna, Vienna

3000

UZ Leuven, Leuven

4000

Centre Hospitalier Universitaire de Liège, Liège

89081

Universitätsklinikum Ulm, Ulm

91054

Universitätsklinikum Erlangen, Erlangen

1105 AZ

Amsterdam UMC, Locatie AMC, Amsterdam

612-896

Inje University Haeundae Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04362254 - A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials | Biotech Hunter | Biotech Hunter